https://anisomycinactivator.co....m/recognition-of-fre
Longitudinal in vivo bioluminescence imaging and immunofluorescence results illustrated that BM-MSCs with overexpression of FNDC5 treatment (FNDC5-MSCs) improved the survival of transplanted BM-MSCs, which ameliorated the increased apoptosis and reduced angiogenesis of BM-MSCs in vivo. Interestingly, FNDC5-OV elevated the secretion of exosomes in BM-MSCs. Also, FNDC5-MSC therapy substantially paid off fibrosis and alleviated injured heart purpose. Conclusions The present study suggested that iri
Like
Comment
Share
